Neurofibromatosis

Neurofibromatosis is a genetic condition in which tumors form on the nerves of the inner ear and cause loss of hearing and balance. Tumors may also occur in the brain and on nerves in the skull and spinal cord, and may cause loss of speech, eye movement, and the ability to swallow. Also called acoustic neurofibromatosis and NF2.

Overview

Feature Articles

Latest Neurofibromatosis News and Research

Researchers discover why people with asthma have lower brain tumor risk

Researchers discover why people with asthma have lower brain tumor risk

Studies outlines novel strategies for detecting cancer and minimal residual disease

Studies outlines novel strategies for detecting cancer and minimal residual disease

Liquid biopsies could help identify, track bladder cancer and peripheral nerve tumors

Liquid biopsies could help identify, track bladder cancer and peripheral nerve tumors

Blood test could enable early detection of cancer in people with neurofibromatosis type 1

Blood test could enable early detection of cancer in people with neurofibromatosis type 1

New, one-stop method developed to avoid de novo genetic disease in embryos

New, one-stop method developed to avoid de novo genetic disease in embryos

Researchers identify a brief window of opportunity to prevent NF1-associated optic pathway glioma

Researchers identify a brief window of opportunity to prevent NF1-associated optic pathway glioma

Antihypertension drug may benefit patients with neurofibromatosis type 2

Antihypertension drug may benefit patients with neurofibromatosis type 2

Optic nerve activity may trigger the formation of vision-harming tumors in children

Optic nerve activity may trigger the formation of vision-harming tumors in children

Sodium fluorescein may improve the safety and outcomes of vestibular schwannoma surgery

Sodium fluorescein may improve the safety and outcomes of vestibular schwannoma surgery

New drug reduces tumor volume and pain in patients with neurofibromatosis type 1

New drug reduces tumor volume and pain in patients with neurofibromatosis type 1

Researchers identify a compound that inhibits growth of schwannomas

Researchers identify a compound that inhibits growth of schwannomas

Nanotechnological drug delivery system enhances the effectiveness of melanoma treatment

Nanotechnological drug delivery system enhances the effectiveness of melanoma treatment

Mouse orthotopic model was used to determine personalized therapy for relapse sarcoma

Mouse orthotopic model was used to determine personalized therapy for relapse sarcoma

Study identifies common characteristics of pediatric vestibular schwannomas

Study identifies common characteristics of pediatric vestibular schwannomas

Study suggests new ways to fight aggressive brain cancer

Study suggests new ways to fight aggressive brain cancer

Study analyzes cancer diagnosis in children with birth defects

Study analyzes cancer diagnosis in children with birth defects

Study finds potential new therapeutic targets for childhood brain tumors

Study finds potential new therapeutic targets for childhood brain tumors

FDA approves first-ever treatment for patients with inoperable plexiform neurofibromas

FDA approves first-ever treatment for patients with inoperable plexiform neurofibromas

Study provides new insight into neurofibromin-deficient ER+ breast cancer

Study provides new insight into neurofibromin-deficient ER+ breast cancer

Mapping genetic links between diseases using data from electronic health records

Mapping genetic links between diseases using data from electronic health records